Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2022 Filed Nov 21, 2022 21:04 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $2.14 | $21,405.00 |
DisclosureSEC source: 0001209191-22-058295 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,798 F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.13 to $2.16 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:02 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 15,000 | $2.88 | $43,164.00 |
DisclosureSEC source: 0001209191-22-041230 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,798 F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $2.86 to $2.89 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price Read SEC document |
| May 24, 2022 Filed May 26, 2022 16:30 UTC |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 516,280 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-032204 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,280 Underlying: Common Stock · 516,280 shares Expires 2032-05-24 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:32 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 75,347 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-032209 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,347 Underlying: Common Stock · 75,347 shares Expires 2032-05-24 F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:34 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 88,097 | $0.00 Strike: $2.81 | $0.00 |
DisclosureSEC source: 0001209191-22-032216 · doc4.xml · derivative · entry 2 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,097 Underlying: Common Stock · 88,097 shares Expires 2032-05-24 F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 23:46 UTC |
Gross Jane ADirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026089 · doc4.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. F2 · derivative.expiration_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 23:57 UTC |
Zaknoen SaraDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026096 · doc4.xml · derivative · entry 1 Zaknoen Sara · CIK 0001602225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. F2 · derivative.expiration_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 23:53 UTC |
SCHIMMEL PAULDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026094 · doc4.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. F2 · derivative.expiration_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 19:39 UTC |
CLARKE JOHN KDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026084 · doc4.xml · derivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. F2 · derivative.expiration_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 23:50 UTC |
Lucas SvetlanaDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026091 · doc4.xml · derivative · entry 1 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. F2 · derivative.expiration_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 26, 2022 Filed Apr 28, 2022 23:42 UTC |
Coughlin TimothyDirector
|
GrantRestricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026087 · doc4.xml · derivative · entry 1 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. F2 · derivative.expiration_date: The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 16:52 UTC |
Shukla SanjayDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 41,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007485 · doc4.xml · derivative · entry 2 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,500 Underlying: Common Stock · 41,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 16:52 UTC |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 83,000 | $0.00 Strike: $5.52 | $0.00 |
DisclosureSEC source: 0001209191-22-007485 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Stock · 83,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 3, 2022, such that this option will be fully exercisable on February 3, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:56 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007489 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:56 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.52 | $0.00 |
DisclosureSEC source: 0001209191-22-007489 · doc4.xml · derivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-02-03 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 3, 2022, such that this option will be fully exercisable on February 3, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:59 UTC |
DENYES NANCYGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 10,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007494 · doc4.xml · derivative · entry 2 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,750 Underlying: Common Stock · 10,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. F3 · derivative.expiration_date: The RSUs are scheduled to vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:59 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 21,500 | $0.00 Strike: $5.52 | $0.00 |
DisclosureSEC source: 0001209191-22-007494 · doc4.xml · derivative · entry 1 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Underlying: Common Stock · 21,500 shares Expires 2032-02-03 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 3, 2022, such that this option will be fully exercisable on February 3, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| January 13, 2022 Filed Jan 18, 2022 13:39 UTC |
Broadfoot Jill MarieChief Financial Officer
|
PurchaseCommon stock | 1,923 | $6.75 | $12,980.25 |
DisclosureSEC source: 0001209191-22-003419 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,112 F1 · balance_after: Includes 178 shares acquired under the Company's 2015 Employee Stock Purchase Plan on November 15, 2021. Read SEC document |
| January 07, 2022 Filed Jan 10, 2022 20:03 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 5,000 | $6.76 | $33,806.50 |
DisclosureSEC source: 0001209191-22-002768 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,798 Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 18:56 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 2,500 | $8.58 | $21,437.50 |
DisclosureSEC source: 0001209191-21-064565 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,798 Read SEC document |
| September 20, 2021 Filed Sep 23, 2021 00:19 UTC |
SCHIMMEL PAULDirector
|
GiftCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057339 · doc4.xml · nonDerivative · entry 3 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 679,143 F2 · ownership.nature: These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000. Read SEC document |
| September 20, 2021 Filed Sep 23, 2021 00:19 UTC |
SCHIMMEL PAULDirector
|
GiftCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-057339 · doc4.xml · nonDerivative · entry 2 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,890 Read SEC document |
| September 20, 2021 Filed Sep 23, 2021 00:19 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 250,000 | $8.00 | $2,000,000.00 |
DisclosureSEC source: 0001209191-21-057339 · doc4.xml · nonDerivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,890 F1 · shares: Represents shares purchased in an underwritten public offering at a public offering price of $8.00 per share. F1 · price: Represents shares purchased in an underwritten public offering at a public offering price of $8.00 per share. Read SEC document |
| May 21, 2021 Filed May 25, 2021 21:03 UTC |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (Right to buy) · Derivative | 207,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001209191-21-035831 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,000 Underlying: Common Stock · 207,000 shares Expires 2025-05-21 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| May 21, 2021 Filed May 26, 2021 01:02 UTC |
Zaknoen SaraDirector
|
GrantStock Option (right to buy) · Derivative | 2,285 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001209191-21-035829 · doc4.xml · derivative · entry 1 Zaknoen Sara · CIK 0001602225 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,285 Underlying: Common Stock · 2,285 shares Expires 2031-05-21 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2024, subject to the recipient's continued service on the Issuer's Board of Directors. Read SEC document |
| May 21, 2021 Filed May 26, 2021 01:04 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (Right to buy) · Derivative | 54,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001209191-21-035833 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2025-05-21 F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| May 21, 2021 Filed May 25, 2021 21:05 UTC |
CLARKE JOHN KDirector
|
SaleCommon Stock | 2,500 | $4.34 | $10,850.00 |
DisclosureSEC source: 0001209191-21-035836 · doc4.xml · nonDerivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 108,083 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These shares were sold to cover fund expenses. F2 · ownership.nature: These shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose. Read SEC document |
| May 21, 2021 Filed May 26, 2021 01:06 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (Right to buy) · Derivative | 59,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001209191-21-035837 · doc4.xml · derivative · entry 2 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common Stock · 59,000 shares Expires 2025-05-21 F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| May 18, 2021 Filed May 20, 2021 08:52 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $4.01 | $40,100.00 |
DisclosureSEC source: 0001209191-21-034292 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,298 F1 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $3.99 to $4.04 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 18, 2021 Filed May 20, 2021 12:55 UTC |
SCHIMMEL PAULDirector
|
PurchaseCommon Stock | 50,000 | $3.98 | $199,000.00 |
DisclosureSEC source: 0001209191-21-034293 · doc4.xml · nonDerivative · entry 3 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 113,023 F2 · price: Represents weighted average price for the shares. The shares were purchased at prices ranging from $3.95 to $4.00 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.nature: These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 00:08 UTC |
Gross Jane ADirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-21-029121 · doc4.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2031-04-28 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 00:13 UTC |
SCHIMMEL PAULDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-21-029126 · doc4.xml · derivative · entry 1 SCHIMMEL PAUL · CIK 0001236447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2031-04-28 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 28, 2021 Filed Apr 29, 2021 20:02 UTC |
CLARKE JOHN KDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-21-029117 · doc4.xml · derivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2031-04-28 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 00:11 UTC |
Lucas SvetlanaDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-21-029123 · doc4.xml · derivative · entry 1 Lucas Svetlana · CIK 0001781292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2031-04-28 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 00:06 UTC |
Coughlin TimothyDirector
|
GrantStock Option (right to buy) · Derivative | 1,428 | $0.00 Strike: $4.21 | $0.00 |
DisclosureSEC source: 0001209191-21-029119 · doc4.xml · derivative · entry 1 COUGHLIN TIMOTHY · CIK 0001376043 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428 Underlying: Common Stock · 1,428 shares Expires 2031-04-28 F1 · derivative.exercise_date: The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors. Read SEC document |
| February 09, 2021 Filed Feb 9, 2021 21:12 UTC |
Shukla SanjayDirector · President and CEO
|
SaleCommon stock | 778 | $7.66 | $5,959.48 |
DisclosureSEC source: 0001209191-21-009112 · doc4.xml · nonDerivative · entry 2 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,298 F3 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019. Read SEC document |
| February 09, 2021 Filed Feb 10, 2021 02:15 UTC |
Broadfoot Jill MarieChief Financial Officer
|
SaleCommon stock | 390 | $7.66 | $2,987.40 |
DisclosureSEC source: 0001209191-21-009113 · doc4.xml · nonDerivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,833 F4 · kind: Sale made by the Reporting Person to satisfy tax withholding obligations in connection with the partial vesting of RSUs granted on February 6, 2019. Read SEC document |
| February 06, 2021 Filed Feb 9, 2021 21:12 UTC |
Shukla SanjayDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009112 · doc4.xml · derivative · entry 3 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,785 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. F4 · derivative.expiration_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. Read SEC document |
| February 06, 2021 Filed Feb 9, 2021 21:12 UTC |
Shukla SanjayDirector · President and CEO
|
Exercise / conversionCommon stock | 1,785 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-009112 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 06, 2021 Filed Feb 10, 2021 02:15 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 892 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-009113 · doc4.xml · derivative · entry 3 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. F5 · derivative.expiration_date: The RSU grant vests as to one-half (1/2) of the total number of units on each one year anniversary of the grant commencing on February 6, 2020. Read SEC document |
| February 06, 2021 Filed Feb 10, 2021 02:15 UTC |
Broadfoot Jill MarieChief Financial Officer
|
Exercise / conversionCommon stock | 892 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-009113 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 6, 2019. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. F3 · balance_after: Includes 178 shares acquired under that Company's 2015 Employee Stock Purchase Plan on November 16, 2020. Read SEC document |
| February 04, 2021 Filed Feb 8, 2021 20:18 UTC |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001209191-21-008634 · doc4.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2031-02-04 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 4, 2021, such that this option will be fully exercisable on February 4, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 04, 2021 Filed Feb 9, 2021 01:08 UTC |
Broadfoot Jill MarieChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001209191-21-008628 · doc4.xml · derivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-02-04 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 4, 2021, such that this option will be fully exercisable on February 4, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 04, 2021 Filed Feb 9, 2021 01:13 UTC |
DENYES NANCYGeneral Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001209191-21-008631 · doc4.xml · derivative · entry 1 DENYES NANCY · CIK 0001640869 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2031-02-04 F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 4, 2021, such that this option will be fully exercisable on February 4, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| February 04, 2021 Filed Mar 9, 2021 16:29 UTC Amendment |
Shukla SanjayDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 112,469 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001209191-21-018992 · doc4a.xml · derivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,469 Underlying: Common Stock · 112,469 shares Expires 2031-02-04 F1 · shares: The option grant was originally intended for 120,000 shares. However, that size of grant was in excess of an annual grant limit in the Issuer's equity plan and, as a result, the portion of the award that was in excess of the plan limit was disgorged. F2 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning March 4, 2021, such that this option will be fully exercisable on February 4, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 21:47 UTC |
CLARKE JOHN KDirector
|
SaleCommon Stock | 7,260 | $4.01 | $29,112.60 |
DisclosureSEC source: 0001209191-20-049578 · doc4.xml · nonDerivative · entry 2 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 110,583 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose. Read SEC document |
| August 28, 2020 Filed Sep 3, 2020 21:47 UTC |
CLARKE JOHN KDirector
|
SaleCommon Stock | 100 | $4.00 | $400.00 |
DisclosureSEC source: 0001209191-20-049578 · doc4.xml · nonDerivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 117,843 F1 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 21:09 UTC |
CLARKE JOHN KDirector
|
SaleCommon Stock | 5,440 | $4.09 | $22,249.60 |
DisclosureSEC source: 0001209191-20-048698 · doc4.xml · nonDerivative · entry 2 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 117,943 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.245, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 21:09 UTC |
CLARKE JOHN KDirector
|
SaleCommon Stock | 2,200 | $4.30 | $9,451.20 |
DisclosureSEC source: 0001209191-20-048698 · doc4.xml · nonDerivative · entry 1 CLARKE JOHN K · CIK 0001219015 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 123,383 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.245 to $4.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · ownership.nature: There shares are owned directly by CHP II, LLP ("CHP"). The general partner of CHP is CHP II Management, LLC, ("CHP Management"). The managing member of CHP Management, John Clarke, Brandon Hull and John Park, are deemed to have voting and dispositive power over the shares and may be deemed to beneficially own certain shares held by CHP. Each reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for Section 16 or any other purpose. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 16:23 UTC |
Shukla SanjayDirector · President and CEO
|
PurchaseCommon Stock | 6,000 | $4.27 | $25,620.00 |
DisclosureSEC source: 0001209191-20-038463 · doc4.xml · nonDerivative · entry 1 Shukla Sanjay · CIK 0001671026 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,291 F1 · price: Represents weighted average price for the shares. The shares were purchased at price ranging from $4.21 to $4.30 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.